18 research outputs found
Cortisol is transported by the multidrug resistance gene product P-glycoprotein.
The physiology of the multidrug transporter P-glycoprotein (Pgp) is still poorly understood. We now show evidence that cell lines with a high expression of Pgp display a reduced accumulation of cortisol and an ATP-dependent outward transport of the hormone. Cortisol efflux from Pgp negative cells does not have such an active component. Further we show that the steroid hormones cortisol, testosterone, and progesterone cause an immediate, dose-dependent increase of daunorubicin accumulation in Pgp overexpressing cells. These effects are particularly apparent for the more lipophilic steroids. These results demonstrate that Pgp may function as a transporter for cortisol and suggest a physiological role of the protein in steroid handling by organs such as the adrenal
Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.
Resistance to multiple antitumour drugs, mostly antibiotics or alkaloids, has been associated with a cellular plasma membrane P-glycoprotein (Pgp), causing energy-dependent transport of drugs out of cells. However, in many common chemotherapy resistant human cancers there is no overexpression of Pgp, which could explain drug resistance. In order to characterise early steps in multidrug resistance we have derived a series of P-glycoprotein-positive (Pgp/+) and P-glycoprotein-negative (Pgp/-) multidrug resistant cell lines, from a human non-small cell lung cancer cell line, SW-1573, by stepwise selection with increasing concentrations of doxorubicin. These cells were exposed to doxorubicin and its fluorescence in nucleus (N) and cytoplasm (C) was quantified with laserscan microscopy and image analysis. The fluorescence N/C ratio in parent cells was 3.8 and decreased both in Pgp/+ and Pgp/- cells with increasing selection pressure to 1.2-2.6 for cells with a resistance factor of 7-17. N/C ratios could be restored partly with verapamil only in Pgp/+ cells. N/C ratio measurements may define a general Pgp-independent type of defense of mammalian cells against certain anticancer agents which may precede Pgp expression in early doxorubicin resistance
Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil.
410 Gone - Infocide in Open Content Communities
Infocide, the purposeful retraction and deletion of an online identity, is accompanied by a confusing set of neologisms such as cybersuicide and information suicide. I distinguish and identify these variations as a form of cyberlanguage. I then explore the complexities of infocide in open content communities (e.g., Python, Wikipedia, Ruby, Debian and Ubuntu) with respect to reasons, enactment, and community reactions. I find that infocides are often prompted by the exhaustion of maintaining an online life, by discontent towards an online community, and over privacy concerns that ones real and online identifies have intersected. While some infocide is concise and complete, infocide is occasionally graduated, such as when one removes aspects of one's identity including advanced status and capabilities (e.g., as an administrator). Because of the temptation to return to one's former identity, infocide is sometimes made irreversible, such as by changing one's account password to a random string. An equally interesting aspect of infocide is a community's reaction. I explore the responses of gratitude, sleuthing (attempting to identify more information, including motivation, about the exit), drama, and the preservation of contributions about the exit
Brain barriers and functional interfaces with sequential appearance of ABC efflux transporters during human development
Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones.
Contains fulltext :
108532.pdf (publisher's version ) (Open Access)Breast cancer resistance protein (BCRP) is known for its protective function against the toxic effects of exogenous compounds. In addition to this, a role in the transport of endogenous compounds has been described. Since BCRP in the plasma membrane was shown to be regulated by sex steroids, we investigated the presence and possible role of BCRP in steroid hormone-producing organs. Therefore, the presence and localization of Bcrp was investigated in endocrine organs of wild-type mice. Furthermore, the interaction of various steroid hormones with human BCRP activity was studied. Quantitative PCR revealed Bcrp mRNA in the pituitary and adrenal glands, pancreas, ovary, testis and adipose tissue. Immunohistochemistry revealed the presence of Bcrp in the cortex of the adrenal gland and in plasma membranes of adipocytes. In the pituitary gland, pancreas, ovary and testis, Bcrp was mainly located in the capillaries. The interaction between BCRP and 12 steroid hormones was studied using membrane vesicles of HEK293-BCRP cells. Estradiol, testosterone, progesterone and androstenedione inhibited BCRP-mediated uptake of (3)H-estrone sulphate (E(1)S) most potently, with calculated inhibitory constant (Ki) values of 5.0 +/- 0.2, 36 +/- 14, 14.7 +/- 1.3 and 217 +/- 13 muM, respectively. BCRP function was attenuated non-competitively, which implies an allosteric inhibition of BCRP-mediated E(1)S transport by these steroids. In conclusion, localization of Bcrp in endocrine organs together with the efficient allosteric inhibition of the efflux pump by steroid hormones are suggestive for a role for BCRP in steroid hormone regulation.01 augustus 201